UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 416

Sortiert nach

Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment

Cancers, 2018-09, Vol.10 (9), p.302

2018

Volltextzugriff (PDF)

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

The New England journal of medicine, 2017-12, Vol.377 (26), p.2531-2544

2017

Volltextzugriff (PDF)

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4767-4773

2009

Volltextzugriff (PDF)

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Blood, 2018-12, Vol.132 (25), p.2639-2642

2018

Volltextzugriff (PDF)

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

Blood, 2013-06, Vol.121 (24), p.4854-4860

2013

Volltextzugriff (PDF)

Expanding the Toolbox of Adoptive Cell Immunotherapy

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1479-1482

2021

Volltextzugriff (PDF)

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

Journal of clinical oncology, 2013-02, Vol.31 (6), p.684-691

2013

Volltextzugriff (PDF)

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Journal of clinical oncology, 2017-12, Vol.35 (36), p.4003-4011

2017

Volltextzugriff (PDF)

Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs

Cancers, 2020-11, Vol.12 (11), p.3301

2020

Volltextzugriff (PDF)

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide

Journal of clinical oncology, 2019-02, Vol.37 (5), p.367-374

2019

Volltextzugriff (PDF)

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

Blood, 2009-06, Vol.113 (23), p.5720-5726

2009

Volltextzugriff (PDF)

Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

The New England journal of medicine, 2013-10, Vol.369 (18), p.1681-1690

2013

Volltextzugriff (PDF)

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

Cancer, 2017-08, Vol.123 (16), p.3061-3072

2017

Volltextzugriff (PDF)

Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice

Cancers, 2023-09, Vol.15 (18), p.4541

2023

Volltextzugriff (PDF)

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

British journal of haematology, 2013-04, Vol.161 (1), p.76-86

2013

Volltextzugriff (PDF)

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer

Journal of ovarian research, 2018-05, Vol.11 (1), p.43-43, Article 43

2018

Volltextzugriff (PDF)

Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

Journal of clinical oncology, 2010-11, Vol.28 (31), p.4740-4746

2010

Volltextzugriff (PDF)

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

Journal of clinical oncology, 2010-02, Vol.28 (6), p.1038-1046

2010

Volltextzugriff (PDF)

Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression

Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies, 2021, Vol.1330, p.33-54

2021

Volltextzugriff (PDF)

1 – 25 von 416

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(343)
Mit Volltextzugriff
(388)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(165)
Science & Technology
(165)
Humans
(155)
Hematology
(97)
Female
(94)
Adult
(93)
Middle Aged
(93)
Male
(87)
Aged
(62)
Immunology
(62)
Transplantation
(60)
Oncology
(53)
Biological And Medical Sciences
(47)
Medical Sciences
(44)
Adolescent
(39)
Hematopoietic Stem Cell Transplantation
(36)
Transplantation, Autologous
(35)
Treatment Outcome
(35)
Hematology, Oncology And Palliative Medicine
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(29)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Expanding the Toolbox of Adoptive Cell Immunotherapy

Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation

Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

Immune responses and long‐term disease recurrence status after telomerase‐based dendritic cell immunotherapy in patients with acute myeloid leukemia

Selinexor in Combination with Decitabine Attenuates Ovarian Cancer in Mice

A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients

The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496

Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer

Temsirolimus Has Activity in Non–Mantle Cell Non-Hodgkin's Lymphoma Subtypes: The University of Chicago Phase II Consortium

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors

Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression

Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

Suchergebnisse filtern